Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

416 ARTÍCULOS , VIENDO DEL 346 AL 360

A Network-Based Perspective in Alzheimer's Disease: Current State and an Integrative Framework

Dragomir A, Vrahatis AG, Bezerianos A.

IEEE J Biomed Health Inform. 2019 Jan;23(1):14-25. doi: 10.1109/JBHI.2018.2863202. Epub 2018 Aug 3.

Facial expression recognition in Alzheimer's disease: A systematic review

Torres Mendonça De Melo Fádel B, Santos De Carvalho RL, Belfort Almeida Dos Santos TT, Dourado MCN.

J Clin Exp Neuropsychol. 2019 Mar;41(2):192-203. doi: 10.1080/13803395.2018.1501001. Epub 2018 Aug 8.

Ocular amyloid imaging at the crossroad of Alzheimer's disease and age-related macular degeneration: implications for diagnosis and therapy

Ong SS, Proia AD, Whitson HE, Farsiu S, Doraiswamy PM, Lad EM.

J Neurol. 2019 Jul;266(7):1566-1577. doi: 10.1007/s00415-018-9028-z. Epub 2018 Aug 28.

Role of physical activity in ameliorating neuropsychiatric symptoms in Alzheimer disease: A narrative review

Veronese N, Solmi M, Basso C, Smith L, Soysal P.

Int J Geriatr Psychiatry. 2019 Sep;34(9):1316-1325. doi: 10.1002/gps.4962. Epub 2018 Aug 29.

Electrophysiological assessment methodology of sensory processing dysfunction in schizophrenia and dementia of the Alzheimer type

Danjou P, Viardot G, Maurice D, Garcés P, Wams EJ, Phillips KG, Bertaina-Anglade V, McCarthy AP, Pemberton DJ.

Neurosci Biobehav Rev. 2019 Feb;97:70-84. doi: 10.1016/j.neubiorev.2018.09.004. Epub 2018 Sep 6.

Noninvasive brain stimulation for behavioural and psychological symptoms of dementia: A systematic review and meta-analysis

Vacas SM, Stella F, Loureiro JC, Simões do Couto F, Oliveira-Maia AJ, Forlenza OV.

Int J Geriatr Psychiatry. 2019 Sep;34(9):1336-1345. doi: 10.1002/gps.5003. Epub 2018 Oct 17.

Disturbances of sleep quality, timing and structure and their relationship with other neuropsychiatric symptoms in Alzheimer's disease and schizophrenia: Insights from studies in patient populations and animal models

Winsky-Sommerer R, de Oliveira P, Loomis S, Wafford K, Dijk DJ, Gilmour G.

Neurosci Biobehav Rev. 2019 Feb;97:112-137. doi: 10.1016/j.neubiorev.2018.09.027. Epub 2018 Oct 9.

Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative

Veitch DP, Weiner MW, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR Jr, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw LM, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2019 Jan;15(1):106-152. doi: 10.1016/j.jalz.2018.08.005. Epub 2018 Oct 13.

In vivo molecular imaging of neuroinflammation in Alzheimer's disease

Chaney A, Williams SR, Boutin H.

J Neurochem. 2019 May;149(4):438-451. doi: 10.1111/jnc.14615. Epub 2018 Nov 26.

Blood-based biomarkers for Alzheimer's disease-An update

Zetterberg H.

J Neurosci Methods. 2019 May 1;319:2-6. doi: 10.1016/j.jneumeth.2018.10.025. Epub 2018 Oct 25.

Every Three Seconds: A Review of an Innovative Documentary on Research and Stigma Surrounding Dementia Across the Globe

Hand MD.

J Gerontol Soc Work. 2019 Apr;62(3):369-373. doi: 10.1080/01634372.2018.1541951. Epub 2018 Oct 30.

Clinical implications of APOE genotyping for late-onset Alzheimer's disease (LOAD) risk estimation: a review of the literature

Marshe VS, Gorbovskaya I, Kanji S, Kish M, Müller DJ.

J Neural Transm (Vienna). 2019 Jan;126(1):65-85. doi: 10.1007/s00702-018-1934-9. Epub 2018 Oct 31.

microRNA diagnostic panel for Alzheimer's disease and epigenetic trade-off between neurodegeneration and cancer

Nagaraj S, Zoltowska KM, Laskowska-Kaszub K, Wojda U.

Ageing Res Rev. 2019 Jan;49:125-143. doi: 10.1016/j.arr.2018.10.008. Epub 2018 Nov 2.

Relating constructs of attention and working memory to social withdrawal in Alzheimer's disease and schizophrenia: issues regarding paradigm selection

Gilmour G, Porcelli S, Bertaina-Anglade V, Arce E, Dukart J, Hayen A, Lobo A, Lopez-Anton R, Merlo Pich E, Pemberton DJ, Havenith MN, Glennon JC, Harel BT, Dawson G, Marston H, Kozak R, Serretti A.

Neurosci Biobehav Rev. 2019 Feb;97:47-69. doi: 10.1016/j.neubiorev.2018.09.025. Epub 2018 Nov 3.

Amyloid beta soluble forms and plasminogen activation system in Alzheimer's disease: Consequences on extracellular maturation of brain-derived neurotrophic factor and therapeutic implications

Angelucci F, Čechová K, Průša R, Hort J.

CNS Neurosci Ther. 2019 Mar;25(3):303-313. doi: 10.1111/cns.13082. Epub 2018 Nov 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias